Efficacy Study of Huatuo Zaizao Pills in Improving of Neural Function in Acute Ischemic Stroke

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 1100 participants.

Also called NCT01758536

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 1,100 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT01758536
Start date
(registry gives no type) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT01758536. Randomized; quadruple masking; primary purpose treatment. Start 2012-12 (registry gives no type); primary completion 2014-12 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Efficacy Study of Huatuo Zaizao Pills in Improving of Neural Function in Acute Ischemic Stroke
Acronym
HTZZP-INF
Intervention (Drug)
Huatuo Zaizao Pills
Lead sponsor
Huashan Hospital (class: other)
Collaborator
Guangzhou Baiyunshan Qixing Pharmarceutical Co Ltd (class: not stated)

Record details

Record id
cardio:ct-nct01758536
Content hash
38cf533c36aba744a8f3175e76c9a1b53c00f2300850895549dffff44eeeb469